Chronic pancreatitis (PC) is a relatively rare disease (45/100,000 population) in Italy, with heterogeneous aetiology, clinical history and treatment.~Patients need to be treated by different specialists, but almost always the gastroenterologist is central in diagnosis and treatment.~The study will be the first National Registry, prospective and will collect data on the history of the disease and its outcomes.~Data will be collected through an electronic data collection form (e-CRF) that the Sponsor (AISP) will make available to the Participating Centres.~Patients enrolled will be both new diagnoses or follow-up visits of patients with a diagnosis already made no more than 1 year before the signing of informed consent for the study in question: only data on the diagnosis and follow-up visits prior to the signing of the informed consent will be collected retrospectively (no more than one year).~Data from patients visited in the Centres included in the study will be collected prospectively.~In addition to the first visits, data will also be collected on follow-up visits that are scheduled according to the clinical need of each patient, which differ according to the stage of the disease
ITARECIPE is a multicenter national registry designed to study the diagnosis and evolution of Chronic Pancreatitis